European medicine watchdog EMA: aware of US J&J vaccine pause
Register now for FREE unlimited access to Reuters.com
AMSTERDAM, April 13 (Reuters) - The European medicines watchdog on Tuesday said it was aware of a decision by its U.S. counterpart to pause the administration of Johnson & Johnson's (JNJ.N) COVID-19 vaccine due to rare instances of blood clots.
In a statement the European Medicines Agency (EMA) said it is not clear there is a link between the vaccine and the incidents and its safety committee is continuing a review announced last week.
Register now for FREE unlimited access to Reuters.com
Writing by Keith Weir
Editing by Chris Reese
Our Standards: The Thomson Reuters Trust Principles.